2021 CMSC Annual Meeting

LATE BREAKING SCIENCE

CREDITS: APA, CME, CNE, CPE, OT, PA, RD, SW
Expiration: 30-Apr-22
Level of Information: Basic, Intermediate, Advanced

Progress in understanding and treating multiple sclerosis evolves continuously and not always on a schedule aligned with scientific meeting deadlines. This session, near the end of the 2021 CMSC Annual Meeting, will address three topics of common interest to the MS care provider team. The session is recommended for all disciplines involved in MS care and will cover the latest information on the prevalence of MS by race in the US, an update on the latest research into candidates for biomarkers in MS, and data collected in the CoViMS registry related to MS management during the current SARSCoV-2 pandemic. All are invited to attend these important discussions, as we head back to our respective roles in the care and treatment of MS.

Presentations and Speakers

Introduction Corey C. Ford, MD, PhD
Race and MS in the US: An Update from the MS Prevalence Workgroup Mitchell T. Wallin, MD, MPH, FAAN
The Search for Relevant Biomarkers in MS, 2021 Mark S. Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
SARS-CoV-2 in MS: CoViMS Registry, Vaccinations, Disease Modifying Therapies, and Recommendations for Management Kottil W Rammohan, MD

You can only claim credits for this On-demand Video if you have not done so for the Live Event.